Literature DB >> 6957993

Gastric cytoprotection by pirenzepine. Role of endogenous prostaglandins.

S J Konturek, T Brzozowski, T Radecki, I Piastucki.   

Abstract

This study compared the effects of pirenzepine, a novel selective antimuscarinic agent, and PGE2 applied topically on the gastric mucosa or parenterally on gastric secretion and formation of ASA and ethanol-induced gastric ulcerations in rats. Pirenzepine given topically in nonantisecretory dose prevented the formation of gastric ulcerations induced by ASA + 0.15 M HCl and absolute ethanol. These cytoprotective effects were comparable to those observed after PGE2 administered intragastrically or subcutaneously. Pirenzepine did not affect ulcer formation by ASA combined with 0.30 M HCl, whereas PGE2 was fully effective under these conditions. The cytoprotective action of pirenzepine was not accompanied by any change in the mucosal generation of PGs, indicating that endogenous PGs do not contribute to the cytoprotective property of this agent.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6957993

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  5 in total

1.  Evaluation of putative cytoprotective properties of antiulcer drugs using quantitative histological techniques.

Authors:  P E O'Brien; G Frydman; R Holmes; C Malcontenti; D Phelan
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

Review 2.  Gastric cytoprotection: a critical appraisal of the concept, methodology, implications, mechanisms and future research prospects.

Authors:  N S Parmar; M Tariq; A M Ageel
Journal:  Agents Actions       Date:  1987-10

Review 3.  Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.

Authors:  A A Carmine; R N Brogden
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

4.  Muscarinic M1 receptor inhibition reduces gastroduodenal bicarbonate secretion and promotes gastric prostaglandin E2 synthesis in healthy volunteers.

Authors:  A Mertz-Nielsen; J Hillingsø; O Eskerod; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

5.  Protection of gastric mucosa in rats. Differences between vagotomy, atropine, and PGE2.

Authors:  D Foschi; F Ferrante; L Varin; P Del Soldato; V Rovati
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.